Skip to main content
Clinical Trials/NCT03922542
NCT03922542
Recruiting
Phase 2

Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia

Price Vision Group1 site in 1 country510 target enrollmentApril 16, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Keratoconus
Sponsor
Price Vision Group
Enrollment
510
Locations
1
Primary Endpoint
Change in maximum keratometry
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.

Registry
clinicaltrials.gov
Start Date
April 16, 2019
End Date
July 1, 2026
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Documented keratoconus or ectasia after refractive surgery

Exclusion Criteria

  • Insufficient corneal thickness
  • Ocular condition that may predispose the eye to complications
  • History of chemical injury or delayed epithelial healing
  • Condition that would interfere with or prolong epithelial healing
  • Known sensitivity to treatment medications
  • Pregnancy

Outcomes

Primary Outcomes

Change in maximum keratometry

Time Frame: 6 months

assessed by corneal tomography

Secondary Outcomes

  • Change in uncorrected distance visual acuity(6 months)
  • Change in corrected distance visual acuity(6 months)

Study Sites (1)

Loading locations...

Similar Trials